What could make HTAs more industry-friendly?

The European biotech industry is calling for a robust and transparent framework in which HTA would be a tool to encourage development of new and innovative therapies for the benefit of patients, whilst allowing health care planners to appropriately fund and manage resources effectively.

Latest Faq